Artificial tears sales will expand through 2036, with sodium hyaluronate based artificial tears at 28.4% within the product type segment and solution at 49.7% of the dosage form category in 2026. The market is estimated at USD 3.9 billion in 2026 and is forecast to record a 5.2% CAGR between 2026 and 2036.